Category Archives: Total Legalization

Let’s make marijuana legal worldwide:)

AZ Marijuana Cards Likely to Be Accepted at Nevada Dispensaries

http://azmarijuana.com/ By:   |   Posted : Aug.14.14

Nevada Marijuanahttp://azmarijuana.com/arizona-medical-marijuana-news/nevada-dispensaries-accept-arizona-marijuana-cards/

Authorities in Nevada are working on a plan that would allow medical marijuana patients from other states, including Arizona, to purchase medical marijuana at Nevada dispensaries, which will be opening in early 2015.

The bureau chief of the Nevada Division of Public and Behavioral Health said that Nevada’s new medical marijuana program will allow Arizona residents to shop at dispensaries if they are part of the medical marijuana program in Arizona.

Brian Sandoval, the governor of Nevada, has officially said that up to 66 dispensaries will open all over the state, with the first expected to open in Las Vegas at the beginning of 2015.

According to state law, Nevada dispensaries can choose to honor out of state medical marijuana cardholders as long as the state that issued their license has an electronic database of patients that “allows the Division and medical marijuana dispensaries in (Nevada) to access the database.”

This measure would obviously need to first be approved by authorities in Arizona.  Will Humble, director of the Arizona Department of Health Services, is hesitant to believe that this law would ever work out in conjunction with Arizona cardholders because the system in which medical marijuana is sold and regulated is specific to Arizona dispensaries.  However, Nevada authorities are confident that once the organized system is functioning by early 2015, their dispensaries won’t even need to access the database in Arizona, and that onsite dispensary agents will be able to validate the out-of-towners’ licenses.

There are more than a few details that need ironing out, but if all goes according to plan, Arizona medical marijuana cardholders and other states will have a few more reasons to visit Las Vegas next year.

 

CDPHE Meeting on Retail Marijuana Surveillance – Thursday 8/14/2014-Patients and Press *Not* Invited

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP

{Denver} — The Colorado Department of Public Health and Environment
(CDPHE) will be holding an all-day meeting on Thursday, Aug. 14, concerning
their expanding roles in “retail marijuana surveillance” and other areas.

*PHYSICAL LOCATION OF MEETING*
Courtyard Marriott Cherry Creek
Skyline Ballroom
1475 South Colorado Blvd.
Denver, CO 80222
Workshop begins at 8:30 am

The CDPHE had previously only regulated medical marijuana. Their new roles in retail marijuana involve at least 6 different departments within the CDPHE. (See page 10 of “Marijuana and CDPHE” presentation below.)

The meeting will be held at the Courtyard Marriott in Denver, but there
will also be a live webinar available (See below for details.)

According to the CDPHE, “no media” will be allowed to attend the meeting,
and the agenda shows that “no patients” have been invited to share their
views in any manner, even though the subject matter directly concerns them.

The Cannabis Press Association (CPA), working with the Patient and
Caregivers Rights Litigation Project (PCRLP), discovered the meeting, after
several patients received an email invitation asking them to register for
the meeting, which was apparently sent accidentally by the CDPHE to the
wrong email distribution list.

In the email, Elyse Contreras, Programs Coordinator for the Retail
Marijuana Program & Medical Marijuana Research Grant Program at the CDPHE,
stated that the purpose of the Aug. 14 meeting is “to update our local
partners on latest information regarding marijuana surveillance, prevention
efforts, medical research, lab regulations, infused product safety and
more!”

Contreras’ invitation stated that “no media” would be allowed to attend.

When the CDPHE discovered they had sent the email invitation to patients in
error, they immediately removed the online registration form from their
website.

The Cannabis Press Association filed a Colorado Open Records Act (CORA)
request last week, asking for the location and webinar login information
for the meeting, as well as a request for the list of invitees to the
meeting.

The CDPHE ignored the CORA requests. However, CPA was able to obtain the
information from reliable sources. (See below.)

*SURVEILLANCE OF PREGNANT WOMEN*
Many topics will be covered at the all-day meeting. A primary focus will be
how the CDPHE will be performing “surveillance” on pregnant women to
determine whether cannabis used during pregnancy is harmful to children.

According to a “Marijuana and Pregnancy” presentation on the CDPHE website,
one of the new CDPHE programs includes “Birth Registry Surveillance”, which
is defined as “surveillance to determine if marijuana could be a factor in
the development of adverse birth outcomes” and includes a “thorough review
of maternal medical records” (See page 9 of “Marijuana and Pregnancy”
presentation below.)

Kathleen Chippi of the Patient and Caregiver Rights Litigation Project sees
this as another attack on patients. “This secret meeting is just another
attack on medical marijuana patients. They want to screen all birth mothers
for cannabis? The CDPHE doesn’t test new moms for GMOs, pesticides,
fracking fluids, caffeine, sugar, or pharmaceutical chemicals, so why focus
on THC, which has been used safely by humans for over 10,000 years?
Cannabis was actually prescribed commonly to ease pregnancy and the
birthing process before it was made illegal in 1937. Natural cannabinoids
(endocannabinoids) are actually abundant in all breast milk and research
has shown that they are essential to a newborn’s development.”

See: Cannabinoids, like those found in marijuana, occur naturally in human
breast milk
http://www.naturalnews.com/036526_cannabinoids_breast_milk_THC.html#ixzz3AKr2v8PH

===================================================================

*MEETING AGENDA*
Click here for agenda for the Aug. 14, 2014 CDPHE/DOR meeting:
http://cannabispressassociation.com/docs/CDPHE.Agenda.for.State.Local.Workshop-8.14.14.pdf

NOTE: The CDPHE claims that this is not a public meeting, but have refused
to provide a list of the official invitees. If you want to attend in
person, it is recommended to arrive early to try to cajole a seat out of
your public officials.

===================================================================
*WEBINAR LOGIN INFORMATION*
From: “Contreras – CDPHE, Elyse” <elyse.contreras@state.co.us>
Date: August 13, 2014 10:51:24 AM MDT
To: undisclosed-recipients:;
Subject: 8/14 Marijuana Webinar Details
Marijuana Workshop for State and Local Public Health

Follow the directions below to join the webinar beginning at 8:30 am
Thursday, August 14th. This is an all day work shop, the agenda is
attached.

This meeting is intended to allow local public health agency
representatives the opportunity to learn more abut marijuana regulation in Colorado.  No public comment or questions will be taken as the meeting is not considered an open meeting as defined in the Colorado Open Meetings Law, Section 24-6-401 et seq. 

Questions on the topics discussed can be
sent to medical.marijuana@state.co.us.

To join the meeting:
https://cdphe.adobeconnect.com/r6e3dlu1pg2/
—————-
If you have never attended an Adobe Connect meeting before:

Test your connection:
https://cdphe.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/products/adobeconnect.html

Elyse Contreras
Programs Coordinator
Retail Marijuana Program & Medical Marijuana Research Grant Program
P 303.692.6455  |  F 303.782.0904
4300 Cherry Creek Drive South, Denver, CO 80246
elyse.contreras@state.co.us
===================================================================

*RELATED CDPHE PRESENTATIONS*
“Marijuana and CDPHE” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.and.CDPHE.Presentation.CORA4.pdf

“Marijuana and Pregnancy” presentation
http://cannabispressassociation.com/docs/CDPHE.Marijuana.Pregnancy.Presentation.pdf

===================================================================
NOTE: This information was obtained as a public service by volunteers
working with the Cannabis Press Association (CPA), working with the Patient
and Caregivers Rights Litigation Project (PCRLP). Please be generous and
make a donation today.

===================================================================

For immediate release: Aug. 13, 2014

Cannabis Press Association
http://www.cannabispressassociation.com/

Patient and Caregiver Rights Litigation Project
http://www.cannabislawsuits.com/
888-EAT-HEMP


Provided as a Public Service by the:
Cannabis Press Association
“Fighting over 77 years of lies and mis-information
with over 10,000 years of history and fact.”
Web: http://www.cannabispressassociation.com/
Email: info@cannabispressassociation.com

***Note from Anna: I wish the DEA officers went after legal (and illegal) methamphetamine,steroid, and Prozac abusers with the same intensity used for illegally profiling legal medical marijuana patients.

Colorado has sold out to big pharmaceutical companies and their petty political lobbyists. It’s disturbing to watch how easy it is for judges and cops to abuse the weakest among them while running like their asses are on fire away from violent offenders on legally-distributed methamphetamines.

Stats on Meth in Colorado:

http://www.justice.gov/archive/ndic/pubs4/4300/meth.htm

National Drug Intelligence Center
Colorado Drug Threat Assessment
May 2003

“…Methamphetamine abuse is increasingly prevalent in Colorado. The number of methamphetamine-related treatment admissions to publicly funded facilities in the state increased from 1,748 in 1997 to 2,037 in 2001, according to data from ADAD. (See Table 1 in Overview section.) Since 1999 treatment admissions for methamphetamine abuse have increased each year, while admissions for cocaine, heroin, and marijuana have declined. According to ADAD, more than 83 percent of patients treated for methamphetamine abuse in 2001 were Caucasian, 54 percent were male, and nearly 33 percent were 35 or older. Nearly 43 percent of methamphetamine abusers treated during 2001 smoked the drug, 32 percent injected it, 19 percent snorted it, and 6 percent used some other method or multiple methods of administration.”

http://www.narconon.org/drug-information/colorado-drug-addiction.html

From Narconon International:

“…Colorado is crossed by eight Interstates: I-15, I-25, I-70, I-76, I-80, I-84, I-90 and I-94. The central location and high ethnic population of Denver and its suburbs makes it a perfect distribution center for drugs coming into the U.S. across the Canadian border, or for drugs being trafficked north from the Southwest border. Fifteen Ports of Entry (POE) from Canada exist in Montana, and Interstates 15 and 90 link these POEs with Denver and Salt Lake City, both major drug distribution points.

…The most dangerous aspect of the drug scene in Colorado and its cities is that drug trafficking and use is on the increase. The biggest threat is the highly addictive and physically damaging ice methamphetamine. Recent supplies of meth have been more pure and lower cost than earlier supplies.”

From Johnny Green at the Weed Blog April 3, 2013:

http://www.theweedblog.com/marijuana-patents-us-patents-on-medical-procedures-involving-cannabinoids/

Spain Study Confirms Hemp Oil Cures Cancer
http://www.endalldisease.com/spain-st…

Federal Government Reports that Marijuana Kills Cancer Cells
http://www.nbcnews.com/id/51148243/ns…

US Patent 4837228
Cannabichromene (CBC)
http://www.google.com/patents/US4837228

US Patent 4189491
Glaucoma Treatment
http://www.google.com/patents/US4189491

US Patent 5631297
Anandamide Compounds
http://www.google.com/patents/US5631297

US Patent 6132762
Pain, inflammation and arthritis
http://www.google.com/patents/US6132762

US Patent 6410588
Cannabidiol and inflammatory diseases
http://www.google.com/patents/US6410588

US Patent 6974568
Treatment for coughs
http://www.google.com/patents/US6974568

US Patent 6630507
Inflammatory and autoimmune diseases
Strokes, Alzheimer’s and Parkinson’s
http://www.google.com/patents/US6630507

US Patent 7741365
Novel polycyclic cannabinoid analogs
http://www.google.com/patents/US7741365

US Patent 7597910
Prostate cancer and prostatitis
http://www.google.com/patents/US7597910

US Patent 7977107
Detecting traces of cannabinoids
http://www.google.com/patents/US7977107

US Patent 8071641
Diabetes and insulitis
http://www.google.com/patents/US8071641

US Patent 8242178
Cannabidiol and autoimmune hepatitis
http://www.google.com/patents/US8242178

US Patent 8034843
Nausea, vomiting and motion sickness
http://www.google.com/patents/US8034843

US Patent Application 20100292345
Cannabigerol (CBG)
http://www.google.com/patents/US20100…

US Patent Application 20080181942
Multiple sclerosis and MS relapse
http://www.google.com/patents/US20080…

US Patent Application 20090197941
Chronic Obstructive Pulmonary Disease
http://www.google.com/patents/US20090…

US Patent Application 20100204312
Treating cell proliferation and cancers
http://www.google.com/patents/US20100…

US Patent Application 20080262099
Inhibition of tumour cell migration
http://www.google.com/patents/US20080…

US Patent Application 20100222437
Gastrointestinal inflammatory and cancers
http://www.google.com/patents/US20100…

Cannabis and Cannabinoid Research Studies…

Scientific Proof Cannabinoids Kill Cancer Cells :

http://youtu.be/mFBBTnv5Xbs

http://redd.it/18qiwn
http://phoenixtears.ca
http://www.phoenixtearsfoundation.com…

Copy and paste links into address bar (one at a time) :

ncbi.nlm.nih.gov/pubmed/19638490
ncbi.nlm.nih.gov/pubmed/22776349
ncbi.nlm.nih.gov/pubmed/16682966
ncbi.nlm.nih.gov/pubmed/12648025
ncbi.nlm.nih.gov/pubmed/19914218
ncbi.nlm.nih.gov/pubmed/15026328
ncbi.nlm.nih.gov/pubmed/16893424
ncbi.nlm.nih.gov/pubmed/15361550
ncbi.nlm.nih.gov/pubmed/19889794
ncbi.nlm.nih.gov/pubmed/19015962
ncbi.nlm.nih.gov/pubmed/19608284
ncbi.nlm.nih.gov/pubmed/17237277
ncbi.nlm.nih.gov/pubmed/11586361
ncbi.nlm.nih.gov/pubmed/14692532
ncbi.nlm.nih.gov/pubmed/16571653
ncbi.nlm.nih.gov/pubmed/18286801
ncbi.nlm.nih.gov/pubmed/16250836
ncbi.nlm.nih.gov/pubmed/17934890
ncbi.nlm.nih.gov/pubmed/12052046
ncbi.nlm.nih.gov/pubmed/19189054
ncbi.nlm.nih.gov/pubmed/18354058
ncbi.nlm.nih.gov/pubmed/19047095
ncbi.nlm.nih.gov/pubmed/10913156
ncbi.nlm.nih.gov/pubmed/9653194
ncbi.nlm.nih.gov/pubmed/18088200
ncbi.nlm.nih.gov/pubmed/16909207
ncbi.nlm.nih.gov/pubmed/17342320
ncbi.nlm.nih.gov/pubmed/19059457
ncbi.nlm.nih.gov/pubmed/12723496
ncbi.nlm.nih.gov/pubmed/19442536
ncbi.nlm.nih.gov/pubmed/16728591
ncbi.nlm.nih.gov/pubmed/19539619
ncbi.nlm.nih.gov/pubmed/16500647
ncbi.nlm.nih.gov/pubmed/19189659
ncbi.nlm.nih.gov/pubmed/14617682
ncbi.nlm.nih.gov/pubmed/18938775
ncbi.nlm.nih.gov/pubmed/11106791
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/19442435
ncbi.nlm.nih.gov/pubmed/15451022
ncbi.nlm.nih.gov/pubmed/18197164
ncbi.nlm.nih.gov/pubmed/16835997
ncbi.nlm.nih.gov/pubmed/11903061
ncbi.nlm.nih.gov/pubmed/17675107
ncbi.nlm.nih.gov/pubmed/17202146
ncbi.nlm.nih.gov/pubmed/19425170
ncbi.nlm.nih.gov/pubmed/18454173
ncbi.nlm.nih.gov/pubmed/17065222
ncbi.nlm.nih.gov/pubmed/10700234
ncbi.nlm.nih.gov/pubmed/16787257
ncbi.nlm.nih.gov/pubmed/15958274
ncbi.nlm.nih.gov/pubmed/16139274
ncbi.nlm.nih.gov/pubmed/16624285
ncbi.nlm.nih.gov/pubmed/16616335
ncbi.nlm.nih.gov/pubmed/11269508
ncbi.nlm.nih.gov/pubmed/19690545
ncbi.nlm.nih.gov/pubmed/12511587
ncbi.nlm.nih.gov/pubmed/20307616
ncbi.nlm.nih.gov/pubmed/16818634
ncbi.nlm.nih.gov/pubmed/17952650
ncbi.nlm.nih.gov/pubmed/16818650
ncbi.nlm.nih.gov/pubmed/16596790
ncbi.nlm.nih.gov/pubmed/15638794
ncbi.nlm.nih.gov/pubmed/15275820
ncbi.nlm.nih.gov/pubmed/12133838
ncbi.nlm.nih.gov/pubmed/18339876
ncbi.nlm.nih.gov/pubmed/9771884
ncbi.nlm.nih.gov/pubmed/10570948
ncbi.nlm.nih.gov/pubmed/12182964
ncbi.nlm.nih.gov/pubmed/19229996

 

University of Arizona Drops Researcher Studying Medical Marijuana for Veterans

Brittny Mejia, The Republic | azcentral.com 11:49 a.m. MST July 2, 2014

http://www.azcentral.com/story/news/arizona/2014/07/02/ua-drops-researcher-studying-medical-marijuana-vets/11956323/

The University of Arizona has abruptly ended its support of a researcher who was leading a controversial and first-of-its kind study on medical marijuana use for veterans with post-traumatic stress disorder.

Dr. Sue Sisley, the principal investigator, had approval from the Food and Drug Administration and the U.S. Public Health Service, as well as conditional approval from the UA Institutional Review Board for the study of marijuana’s effect on PTSD. Her goal was to start the study this summer.

Late last week, university officials told her they wouldn’t renew her contract, essentially stopping the study before it started.

She said she believes that action occurred because the study became too controversial, at one point creating backlash in the Legislature.

“What they’ve done is harm the veterans by delaying this very crucial research by possibly a year or more when (veterans) really needed this research to be done,” Sisley said. “We were right on the cusp of being able to implement this research and the UofA just cut it off at the knees and hurt the veteran community in Arizona more than they’ll ever realize.”

The study, which was to include 70 veterans suffering from PTSD, would have been the first and only randomized controlled trial in the country looking at marijuana in treating post-traumatic stress disorder, Sisley said.

Sisley, who works at the UA’s Phoenix medical school, said university officials e-mailed her on Friday saying they would not renew her appointment as assistant director in the Arizona Telemedicine Program and as coordinator of special projects in research administration at the Phoenix medical school, effective Sept. 26.

On Monday afternoon, she said she also received a letter saying that her academic appointment as clinical assistant professor in the Psychiatry Department would end, meaning she can no longer perform her research at the UA.

“It’d be different if it was just one of the three positions,” she said. “But this is an across-the-board termination, so it suggests that this is a direct attack on the fact that I was at the forefront of very controversial research.”

George Humphrey, assistant vice president for public affairs for the Arizona Health Sciences Center, said in an e-mail that the university would not comment on personnel matters.

But he said that the university has policies and procedures that would allow for faculty who are departing the university to continue to pursue their research projects elsewhere.

In May, the UA signed a contract with Sisley and the Multidisciplinary Association for Psychedelic Studies, a non-profit research and educational organization, to enable Sisley to conduct the randomized controlled trial at the university. The non-profit sponsored the study, and committed to providing the funding, which would total nearly $1 million.

Sisley, who has spent five years trying to bring the medical-marijuana study to fruition, said she believes the decision not to renew her contracts resulted from her education and advocacy on the barriers to marijuana research, which include finding a home and funding for the research.

She said she plans to appeal and has reached out to the American Civil Liberties Union and other organizations.

While Sisley said her primary focus is on scientific and academic pursuits, she added that she has become politically active because of the barriers on federally regulated marijuana research.

Earlier this year, when state Sen. Kimberly Yee blocked a hearing of a bill that could have helped fund Sisley’s study, some residents launched a recall effort and the UA logo became affiliated with the effort to recall her, Sisley said.

In April, Sisley said she received a phone call from Joe Garcia, senior vice president for Health Sciences, regarding her political activism.

He instructed her to provide a letter for the UA administration team, wherein she explained she did not participate in the recall effort or link the university to it. She also stated in the e-mail that she never used university resources to participate in activism. Garcia was unavailable for comment.

Sisley said she never received a response to her e-mail.

“They can call it a non-renewal, they can say I wasn’t fired, but when you strip a faculty member of 100 percent of their salary support, it’s pretty clear what they’re doing,” she said. “I think that this is retaliation for trying to provide the public with knowledge about the barriers to marijuana research.”

The university has not received any political pressure to terminate any employees, said Chris Sigurdson, senior associate vice president of university relations. Sigurdson said the university has been supportive of medical-marijuana research and had gone to the Legislature in the past to voice that support.

Some reasons for non-renewal include funding changes and changes within a unit, according to Helena Rodrigues, director of human resources, strategy and planning at the UA.

“Any individual employee should not have an expectation of continued employment past the end of an employment-contract period,” Rodrigues said.

While the FDA approved Sisley’s study three years ago, she was awaiting a permit from the U.S. Drug Enforcement Administration, which she couldn’t receive until the UA gave her a location to house the study. The study would have measured how specific doses could treat PTSD symptoms.

Sisley said if she were forced to take her research to another university, she would have to go through a new review process, which could take another year.

State Rep. Ethan Orr, R-Tucson,who earlier this year introduced the bill in the Legislature that would help fund Sisley’s study, said the research would have been useful in understanding medical marijuana.

“I think if she does not do the study at the UofA, I hope that another university would pick her up and pick this research up because it’s very valuable to us,” Orr said. “I hope that the UofA will continue to look at this type of research as well.”

Ricardo Pereyda, a former UA student and combat veteran with PTSD, said cannabis works better for treating his symptoms than prescription medication.

But Pereyda, 32, said he believes it’s essential to conduct a study like Sisley’s to provide concrete answers to whether marijuana works in treating PTSD.

“Thousands of veterans have committed suicide in the time that this study has been delayed,” Pereyda said. “How many more are going to continue to commit suicide? This could potentially be something that could see a reduction in those numbers.”

 

****Note from Anna: How many more mentally ill people have to die to please big pharmaceutical companies? When are the citizens, whose tax dollars are used to employ and maintain the lifestyles of *all* city,state, end federal politicians, going to have their needs put first? Obama should immediately fully legalize hemp and medical marijuana for nationwide(as well as global) medical and retail purposes. 

It would give millions of citizens the freedom to grow their medicines, improve their health conditions, and become financially stable through farming. It would rebuild America’s economy.

Federal Trade Commission Jessica L. Rich Office of the Director Bureau of Consumer Protection Filed Comment

August 1, 2014

“Dear National Telecommunications and Information Administration:

As the Director of the Federal Trade Commission’s Bureau of Consumer Protection, I appreciate this opportunity to respond to your June 4, 2014 request for comment (“Request for Comment”) regarding how developments in “Big Data” affect consumer privacy and the interests reflected in the Administration’s Consumer Privacy Bill of Rights.

…As the nation’s leading consumer privacy enforcement agency, the FTC has
addressed the privacy implications of Big Data through its law enforcement and policy work, and will continue to focus on these issues as part of its consumer protection mission.

…The FTC’s focus on privacy dates back to enactment of the Fair Credit Reporting Act (“FCRA”) in 1970. The FTC has been the primary enforcer of this law, which protects sensitive consumer report information – that is, data used for decisions involving credit, employment, insurance, and other eligibility determinations – from disclosure to unauthorized persons.

...The views expressed in this letter are my own and do not necessarily reflect the views of the Federal Trade Commission or any particular Commissioner.

2 15 U.S.C. §§ 1681-1681x (2012).

….Sensitive consumer report information – that is, data used for decisions involving credit,employment, insurance, and other eligibility determinations – from disclosure to unauthorized

Beginning in the mid-1990s, the FTC began to examine consumer privacy issues extending beyond the concerns reflected in the FCRA. The Commission’s primary source of legal authority is Section 5 of the FTC Act,3 which empowers the Commission to take action against deceptive or unfair practices.

…The Commission also enforces numerous sector-specific statutes, including the Gramm-Leach-Bliley Act,4 the Children’s Online Privacy Protection Act, the CAN-SPAM Act,6 and the Telemarketing and Consumer Fraud and Abuse Prevention Act and the associated Do Not Call Rule.

Under these laws, the Commission has brought a variety of privacy-related cases, including cases against companies engaged in Big Data analytics, such as Twitter, Google, and Facebook. The FTC also educates consumers and businesses, conducts studies, testifies before Congress, hosts public events, and writes reports regarding the privacy and security implications of technologies and business practices that affect consumers. Recently, much of the FTC’s privacy work has addressed Big Data issues.

FTC INITIATIVES RELATING TO BIG DATA
1. Exploration of Emerging Issues

…Over the past several years, the Commission has hosted a number of workshops
addressing the proliferation of Big Data and its privacy ramifications.

In 2009 and 2010, the Commission hosted a series of public roundtables examining the myriad ways in which companies can amass “little data” from consumers and turn it into comprehensive databases and The Commission discussed these approaches its Privacy Report and the White House addressed them its recent report on Big Data.

…See FED. TRADE COMM’N, PROTECTING CONSUMER PRIVACY IN AN ERA OF RAPID CHANGE:

…RECOMMENDATIONS FOR BUSINESSES AND POLICYMAKERS (2012) [hereinafter PRIVACY REPORT], available at http://ftc.gov/os/2012/03/120326privacyreport.pdf;

EXECUTIVE OFFICE OF THE PRESIDENT, BIG DATA: SEIZING OPPORTUNITIES, PRESERVING VALUES, available at
http://www.whitehouse.gov/sites/default/file/docs/big_data_privacy_report_5.1.14_final_print.pdf (2014).

…In particular, the roundtables examined the ways in which companies collect data from consumers, including through social networking sites, mobile devices, and contracts with data brokers. Based on the roundtables, the Commission issued its Privacy Report setting forth a generally-applicable framework for addressing consumer privacy issues.

More recently, in November 2013, the Commission held a public workshop to explore an emerging form of consumer data collection – through sensors placed in everyday devices that connect to the Internet, a phenomenon known as “the Internet of Things.”

…Participants discussed the privacy issues raised by the Internet of Things – including the increased ubiquity and invisibility of data collection, the challenges of providing notice and choice in a “no screen” environment, and what incentives exist for designing products with privacy and security in mind.

…Materials from the workshop, including video and transcripts, are available on the FTC website and the Commission plans to issue a report on the workshop in the coming months.

…In the spring of 2014, the FTC also hosted a series of seminars to examine the privacy implications of three new technologies and business models that further enable companies to gather Big Data about consumers:

(1) mobile device tracking of consumers as they move within and among retail stores and other brick-and-mortar businesses

(2) predictive score modeling, through which companies can determine consumers’ likely response to product and service offers, and

(3) consumer generated and controlled health data that is not covered by the Health Insurance Portability and Accountability Act.

The series featured academics, business and industry representatives, and consumer advocates for two-hour discussion sessions, as well as a request for public comments.  Materials from the seminars, including video and transcripts, are available on the FTC website.

…See Press Release, Fed. Trade Comm’n, FTC to Host Public Roundtables to Address Evolving Consumer Privacy Issues (Sept. 15, 2009), available at:
 http://www.ftc.gov/news-events/press-releases/2009/09/ftc-host-public-roundtables-address-evolving-consumer-privacy.

See PRIVACY REPORT, supra note 8, at 15-72.

Trade Comm’n, Internet of Things – Privacy and Security in a Connected World (Nov. 19, 2013), available at http://www.ftc.gov/news-events/events-calendar/2013/11/internet-things-privacy-security-connected-world.&#8221;

‘Chemical Threat': Disaster Looms as Kiev Shells Fall Near Donetsk Plant

http://rt.com/news/179336-chemical-disaster-donetsk-plant/

Rt.com August 11, 2014

Photo from www.stirol.net

Ukraine is at risk of an environmental disaster as Kiev’s army continues to bomb the Donestk region, nearly hitting its largest chemical plant that stores lethal agents, the plant’s spokesperson warned. The minimum impact zone would be at least 300 km.

READ MORE: ‘Spreading the truth’: Spanish volunteers join fight against Kiev in E. Ukraine (VIDEO)

For the past three weeks, the Ukrainian army has been intensely shelling Gorlovka, located in Ukraine’s Donetsk region — home to the nation’s largest chemical plant, Stirol.

“Due to the irresponsible actions of the Ukrainian army, citizens of Ukraine, Russia, and Belarus are exposed to a deadly threat from an ecological disaster on a daily basis, the size of which cannot be predicted,” Pavel Brykov, a spokesman for the plant, said in a YouTube message on Sunday.

A still from YouTube video by SputnikTV allegedly showing remains of a shell at the territory of Gorlovka chemical plant in eastern Ukraine

According to Brykov, an accident at the plant could cause a toxic leak of nitrochlorobenzene – a lethal substance which, if it enters the human body, affects the liver, heart, and bone marrow, causing death.

The minimum impact of the accident would be at least 300 kilometers, Brykov said, adding that the risks of the accident are being silenced in the Ukrainian media.

Stirol is part of the OSTCHEM holding company that belongs to Ukrainian businessman Dmitry Firtash.

Earlier, Firtash claimed there is no risk of a catastrophe since there are no lethal agents stored at the plant. He added that back in May, when the shelling of the region began to intensify, the plant stopped the synthesis and processing of the colorless gas ammonia and evacuated all of its workers.

A still from YouTube video by SputnikTV allegedly shows remains of a shell near the facilities of Gorlovka chemical plant in eastern Ukraine

In their offensive against the eastern Ukrainian militia, Kiev troops have been using multiple-rocket launchers, such as Grad and Uragan – highly indiscriminate weapons designed for destroying enemy forces in the field. If fired at a city, their lack of precision would likely lead to multiple civilian casualties, increasing the risk of a chemical catastrophe.

Just on Thursday, a unique wooden Orthodox church burned to the ground after being hit by an artillery shell in Gorlovka.STIROL chemical plant in the town of Gorlovka in the Donetsk region (Reuters / Valery Belokryl)

The ongoing fighting in eastern Ukraine has already led to more than 1,300 people – both civilians and military troops – being killed in the conflict, and over 4,000 others being wounded. At the same time, around 118,000 people have been internally displaced and 740,000 others have fled to Russia.

The Stirol plant was involved in an accident that killed six people and injured 26 others a year ago, when a colorless gas ammonia was released into the air during repair work. The incident was one of the biggest in the country’s recent history.

Ukraine is also the site of the world’s worst nuclear power plant accident in history. The catastrophic nuclear disaster happened on April 26, 1986 at reactor number four of the Chernobyl nuclear power plant in Ukraine, which was then one of the USSR republics. The plant is located near the city of Pripyat, some 100 km north of the capital Kiev.

As a result of the explosion and fire, a huge radioactive cloud was spread into the atmosphere, covering thousands of miles of Soviet and European territories. Approximately 100,000 square kilometers of land were significantly contaminated.

Thirty-one out of the 237 people diagnosed with acute radiation sickness died within the first three months of the accident. Overall, up to 985,000 people have died as a result of the incident, mainly from cancer due caused by the radiation, according to Global Research.

City of Fife Asserts Federal Preemption Argument in Marijuana Case, Attorney General Will Defend I-502

http://www.atg.wa.gov/pressrelease.aspx?&id=32237#.U-gdB6NiIwp

FOR IMMEDIATE RELEASE August 06, 2014 Washington State Office of the Attorney General

AGO believes city’s federal preemption argument threatens to destroy marijuana Initiative 502.

OLYMPIA — The Washington State Attorney General’s Office will vigorously defend I-502, the initiative legalizing marijuana, against an argument raised by the city of Fife.

The city claims that the state law is invalid because it conflicts with federal law.

If a court accepts that argument and it is upheld on appeal, it would mean the end of the state system for legal marijuana sales in Washington.Last week the AGO moved to intervene in cases in Fife and Wenatchee challenging those cities’ bans on marijuana businesses.

The AGO intervened to ensure a proper interpretation of I-502 and to defend against any argument that federal law preempts I-502. On July 31, Fife filed a motion for summary judgment arguing, among other things, that federal law preempts I-502.

Pierce County Superior Court Judge Vicki Hogan is expected to hear arguments in the case on August 29.

Emphasizing his commitment to make every effort to defend the will of the voters in enacting I-502, Attorney General Bob Ferguson directed Solicitor General, Noah Purcell, to present oral arguments for the state.The first question for the court will be whether I-502 overrides local zoning rules and requires local governments to allow marijuana businesses.

If the court agrees with the formal opinion issued by the AGO in January 2014 concluding that I-502 does not override local zoning requirements, the case will be resolved and Fife’s federal preemption argument will become irrelevant.

(The AGO issued the formal opinion in response to a request from the Liquor Control Board.Read more about that opinion and the opinion process, here.)

If the court disagrees with the AGO’s opinion and decides I-502 requires local governments to allow marijuana businesses, then the court must decide whether I-502 is preempted by federal law. If the court finds I-502 is preempted by federal law,and it is upheld on appeal, the marijuana legalization effort would be destroyed.

“As Attorney General, my job is to make sure the will of the people is upheld,” said Ferguson. “This case and others like it threaten the heart of Initiative 502. We want to participate in all cases like this to defend the will of the voters.”“

Attorney General Ferguson is the lawyer for the people of Washington,” said Washington State Senator Jamie Pedersen, a lawyer who supported I-502. “The voters passed I-502 and it is his job to defend it. I am grateful that Ferguson is getting involved in the Fife case to protect our voters’ decisions.”

Approved by voters in 2012, I-502 legalized the possession and sale of recreational marijuana in Washington and created a system of state licensing and regulation.The cities of Wenatchee and Fife passed local ordinances that prohibit operating marijuana businesses within their cities.

The plaintiffs in SMP Retail, LLC v. Wenatchee, Graybeard Holdings, LLC v. Fife and MMH, LLC v. Fife seek to invalidate these local ordinances so they can sell recreational marijuana.-30-

The Office of the Attorney General is the chief legal office for the state of Washington with attorneys and staff in 27 divisions across the state providing legal services to roughly 200 state agencies, boards and commissions.

Attorney General Bob Ferguson is working hard to protect consumers and seniors against fraud, keep our communities safe, protect our environment and stand up for our veterans.

Visit http://www.atg.wa.gov to learn more.

****Note from Anna: This is a golden opportunity to reshape retail and medical marijuana laws. It’s also an effort to clean house of the cops, judges, politicians, and lobbyists that handed Washington State organic  hemp and marijuana industries to big business.

Contacts: Alison Dempsey-Hall, Acting Communications Director, (206) 442-4482

FDA Eases Restrictions on Experimental Ebola Drug as CDC Warns of ‘Inevitable’ Spread to U.S.

http://rt.com/usa/179100-ebola-fda-drug-cdc-spread/

RT.com August 08, 2014

While Ebola, the deadly disease spreading through parts of West Africa, has no cure, specific treatment or vaccine, there are several experimental drugs being tested in US labs. Now the FDA has lifted its hold on one of those drugs.

The US Food and Drug Administration gave Tekmira Pharmaceuticals verbal confirmation that they modified the full clinical hold the regulatory agency had placed on the company’s experimental TKM-Ebola drug, enabling the potential use on Ebola patients, Tekmira said in a statement.

“We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so,” said Dr. Mark Murray, CEO and president of Tekmira.

“This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols.”

The company, in collaboration with infectious disease researchers from Boston University and the United States Army Medical Research Institute for Infectious Diseases, showed the drug’s ability to protect non-human primates from Ebola in preclinical trials in May 2010, Tekmira said.

A Phase I clinical trial ‒ the first step towards FDA approval ‒ began on humans in January. The agency then approved a fast-track designation for the drug in March, around the same time the Ebola outbreak began in Guinea, Liberia and Sierra Leone. It has since spread to Nigeria. According to World Health Organization figures published on Wednesday, there are over 1,700 suspected and confirmed cases of Ebola in the four countries, and 932 of those patients have died from the disease.

A different drug, ZMapp by Mapp Biopharmaceutical Inc., was used to treat two American aid workers who had contracted Ebola in Liberia. ZMapp, previously only known as “a secret serum,” has not been given the go-ahead to begin human trials yet, Forbes reported. It works by boosting the immune system to battle against Ebola. The treatment consists of antibodies from lab animals exposed to the virus.

After receiving a dose of the serum, both Nancy Writebol and Dr. Kent Brantly were transferred to Atlanta’s Emory University Hospital, near the US Centers for Disease Control and Prevention. Brantly, 33, who is an employee of the international group Samaritan’s Purse, also received a blood transfusion from a 14-year-old Ebola survivor, who had been under his care before. Both American patients appear to be improving, officials have said.

With the arrival of Ebola in the US via the two aid workers ‒ who remain in isolation in Atlanta ‒ CDC Director Tom Frieden told Congress that the disease will “inevitably” spread around the world due to global air travel, but that any outbreak in the US would not be large.

Frieden testified on the epidemic in front of the House Subcommittee on Africa, Global Health, Global Human Rights and International Organizations on Thursday. “It is certainly possible that we could have ill people in the US who develop Ebola after having been exposed elsewhere,” he said in his testimony. “But we are confident that there will not be a large Ebola outbreak in the US.”

As people who have traveled to West Africa and then return to or continue on to other destinations develop Ebola-like symptoms, such as fever and gastrointestinal distress, other nations have begun testing for the disease. On Tuesday, Great Britain announced a person in Wales was being monitored by health officials following a potential exposure to the virus.

On Monday, the US experienced its first scare. Mount Sinai Hospital in Manhattan performed tests on a male patient with high fever and gastrointestinal symptoms, the hospital said in a statement. He arrived in the emergency room Monday morning, and had previously traveled to one of the West African countries where Ebola has been reported. However, by the end of the day, officials confirmed the patient had not contracted the deadly disease.

“We are all connected and inevitably there will be travelers, American citizens and others who go from these three countries ‒ or from Lagos if it doesn’t get it under control ‒ and are here with symptoms,” Frieden said.

But that does not mean that the US will become the next battlefront against the disease, a CDC spokesman clarified after Frieden’s testimony.

“It is inevitable that people are going to show up with symptoms. It is possible that some of them are going to have Ebola,” CDC spokesman Tom Skinner said, according to AFP.

****Note from Anna: The government has just made the entire nation’s citizens research test subjects for the plague. Ebola spreads faster in people with weakened immune systems. The only substance on the planet that can make the immune system strong enough to fight it is cannabis. Obama knows this. Why hasn’t the President legalized cannabis nationwide?

Authors:

Pharmacol Res. Author manuscript; available in PMC Feb 24, 2011.
Published in final edited form as:
PMCID: PMC3044336
NIHMSID: NIHMS182272

“Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response.

Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.”

Endocannabinoids and immune regulation

Info about Ebola: Ebola Hemorrhagic Fever

Washington State Department of Health Medical Marijuana Authorization Practice Guidelines Public Hearing August 8, 2014

Repost for , July 31, 2014

From: Washington State Department of Health
Date:07/25/2014 6:09 PM (GMT-06:00)
To: MEDICALCANNABIS@LISTSERV.WA.GOV
Subject: Medical Marijuana Authorization Practice Guidelines

July 25, 2014
Medical Marijuana Authorization Practice Guidelines
The Department of Health is facilitating a workgroup of representatives from the boards and commissions whose health care professionals can authorize the medical use of marijuana.•  Nursing Care Quality Assurance Commission
•  Board of Naturopathy
•  Medical Quality Assurance Commission
•  Board of Osteopathic Medicine and Surgery

The workgroup will develop draft guidelines to describe the professional practice standards for health care professionals who authorize the medical use of marijuana under chapter 69.51A RCW.

Where:

Department of Health
Point Plaza East
Room 152/153
310 Israel Road SE
Tumwater, WA 98501
360-236-4700

When
August 8, 2014
8:30 a.m.

The public is invited to attend. Thirty minutes have been allotted for public testimony. If you are unable to attend this workgroup meeting, please submit written comments by close of business Thursday, August 7, 2014, at medicalmarijuana@doh.wa.gov.

Agreement on the guidelines may require additional effort by the workgroup, in which case future meetings will be scheduled and notice will be sent to interested persons.

Once completed, the draft guidelines will be shared with each board and commission at regularly scheduled business meetings for review and possible adoption.

***Note from Anna: I am only going to say this once more: If Washington State dispensaries, businesses, and patients don’t unite to put these politicians in line they will be micromanaging your medicines, and taxes in relation to them, from now on. You’ll never be free of the political posturing and bullshit.
If you cannot go please send a proxy to speak for you.
 
If you would like me to write a letter on your behalf use this email address: annajaya67@yahoo.com.
If I get any nonsense, SPAM, or negativity you’ll get blocked and/or your info will be turned over to whoever is necessary.
Activists you can email me for my phone number. I am not certain I will be able to attend the meeting in person because I’m in California on the 7th but if I can make it on a late flight I will.

How Should Marijuana Legalizers Vote For President? Pragmatically-Dr.Jill Stein 2016

http://www.theweedblog.com/how-should-marijuana-legalizers-vote-for-president-pragmatically/

August 19, 2012

Dr. Jill Stein, Green Party Candidate for President

I attempted to make this point in a previous post, but I didn’t convey it very well. Today I received a tweet from a listener who suggested I consider Dr. Jill Stein, the Green Party candidate who won the nomination of her party recently, fending off a challenge from Roseanne Barr. (You may not have taken her seriously, but I never thought the guy from Hercules in New York would be governor of California, so I didn’t count her out.)

So I’m considering it. And I’m considering just who we in the marijuana nation should vote for in the presidential race, especially since LZ Granderson thinks we’re all “idiots”. I think it’s quite rational to factor in whether the man who wants your vote for president would continue to allow body-armored law enforcers with automatic weapons and grenades to break down your door, shoot your dog, terrify your kid, seize your assets, end your scholarship, ruin your career, imprison your family, murder your grandma, and stuff you in a cage for decades for the flower they think you’re growing in the basement.

Whether legalization should be your only consideration, however, is what LZ was critiquing, and I tend to agree that it is simplistic to base one’s vote on just one issue. I’ll say that to one-issue reproductive-rights, gun-rights, and Evangelical voters, too. It’s a big complex world out there and you have to consider how issues are networked. For instance, if I voted for a candidate who’d legalize weed but end net neutrality, I’d be worse off, overall. If I voted for a guy, say, a long-time representative from Texas who’d let Oregon legalize pot farming but also would have no qualms with my home state of Idaho re-criminalizing abortion, my nieces would be worse off. See what I mean?

MITT-ROMNEY-RMONEY

So let’s start with who not to vote for, and that’s Mitt “R-Money” Romney. Besides his recently admitting marijuana isn’t “an issue of significance” to him, and turning his back on wheelchair-bound patients who use cannabis, I just can’t fathom a vote for a guy who bullies the gay kids and ties his dog to the roof of the car on 12-hour trips. That’s enough for me, but I’m willing to listen to arguments for him. I just don’t see how R-Money helps our cause at all, and if you think Obama’s gone hogwild with the medical marijuana crackdown, consider that’s US Attorneys acting with a wink and a nod from the president; imagine them with an outright go-ahead.

There still stands Rep. Ron Paul, raising money and campaigning when his chance of winning the Republican nomination is worse than the chance of Oklahoma Gov. Mary Fallin signing a law tomorrow to legalize mescaline. Oh, how the RevoLutionaries are going to crash my comments section, telling me how much he supports marijuana legalization. He doesn’t – he supports states rights to do such things and that the federal government has no jurisdiction in drug policy. I guess a President Paul would work out well for me in Oregon. but I would weep for my friends in the Red States..”

Ron Paul

Sorry, Paulbots, he’s another guy I have to put in the not to vote for column. If you can explain to me why I want to live in a country with no federal minimum wage, no occupational safety and health standards, no labor unions, no anti-trust enforcement, no estate tax, no tax credits for elderly or child care, no birth citizenship, no funding of family planning, no flag burning, and support of state abortion bans, gay marriage bans, offshore drilling, weakened Social Security, school prayer, teaching creationism, guns everywhere and anywhere, and zygotes defined as citizens in exchange for my state and a few others having the opportunity to legalize weed, I’ll listen.

So then we’re left with President Obama and the major third-party challengers, Libertarian Gov. Gary Johnson and Green Dr. Jill Stein. Given that you can’t vote for Romney, Obama’s been terrible for the marijuana nation, and a third party candidate is not going to win, what do you do?

My friend Cheyanne helping Gov. Gary Johnson get from the hotel parking lot to the event we were both appearing at in Austin, as I take the photo from her car.

 

Yes, Libertarians and Greens, you must face up to the fact that your candidate is not going to become president. All the fervent wishing and desperate hoping will not change the electoral and financial math. That does not diminish the importance of these parties and their candidates running for president. We desperately need more voices than just Republicans and Democrats. (Full disclosure: I’ve appeared at a number of events with Governor Johnson, including moderating a panel including him and former Alaska Senator and presidential candidate, Mike Gravel.)

The fact they are called “third parties” should tell you something. If we lived in a parliamentary system, like Canada or England, multiple parties would exist and coalitions would form and our politics would look very different. But we have a “winner takes all” system and when you research game theory, you’ll find such a system guarantees the kind of duopoly we find in Republicans and Democrats, or an outright monopoly, like we find in Republicans and Democrats on quite a few issues.

Learn how the math of our electoral process demands that we adopt “range voting” and where it’s completely safe to vote third party for president in 2012 by continuing the rant at RadicalRuss.com…

Washington State Attorney General Secures Guilty pleas in Medicaid fraud cases totaling $137,000

OLYMPIA — The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) recently secured guilty pleas against four healthcare providers in four separate Medicaid fraud cases around the state, bringing more than $137,000 back to the state’s Medicaid program.

“The Attorney General’s Office Medicaid Fraud Control Unit helps ensure that dollars allocated for Medicaid services are spent as they were intended,” Attorney General Bob Ferguson said. “Every bit adds up so we encourage people to report fraud when they see it.”

Peggy Ruth Kerr

Charges were filed by the AGO in March against Peggy Ruth Kerr in Thurston County Superior Court, alleging that she attempted to conceal the fact that she and the Medicaid recipient had moved to Nevada for years, where she was ineligible to receive Washington Medicaid benefits.

This week, Kerr pled guilty to three counts of Attempted Medicaid False Statement and has repaid to taxpayers the full $100,000 that she unlawfully collected over the past several years. She will be sentenced in Thurston County Superior Court in November.

The case was investigated by MFCU Investigator David Fenn and prosecuted by Assistant Attorney General Marty Raap.

Chanell Flock

The AGO charged Chanell Flock in Spokane County Superior Court in June 2013, alleging that she billed Medicaid for care she never actually provided to three different recipients from January 2007 through October 2011.

Flock pled guilty on April 7, 2014, to two counts of Medicaid False Statement and has repaid to taxpayers the full $20,053 she unlawfully collected over the past years. MFCU Investigator Larry Carlier conducted the investigation, and Assistant Attorney General Marty Raap prosecuted the case.

Tiamila Davis

The AGO charged Tiamila Davis in Kitsap County Superior Court in November 2013, alleging that she provided healthcare services to a Kitsap County Medicaid recipient while Davis was really living in Louisiana.

Davis pled guilty to counts of First Degree Theft and Medicaid False Statement on April 2, 2014 and agreed to pay $12,326.48 in restitution. Kitsap County Aging and Long Term Care referred the case to the AGO. MFCU Investigator Mariya Kunin investigated, and Assistant Attorney General Marty Raap prosecuted the case.

Eunmi Kim

The AGO charged Eunmi Kim in Snohomish County Superior Court on April 22, 2014.  That day, she pled guilty to Attempted Possession of Stolen Property for receiving Medicaid dollars for individualized care to Medicaid recipients, when in fact she was caring for multiple recipients at the same time.

Kim agreed to pay more than $6,000 in restitution and fines. MFCU Investigator Dave Fenn investigated, and Assistant Attorney General Marty Raap prosecuted the case.

Medicaid Fraud Control in Washington

The Attorney General’s MFCU is responsible for the investigation and prosecution of healthcare provider fraud committed against the state’s Medicaid program. The unit also coordinates with local law enforcement authorities to investigate and prosecute abuse and neglect in cases involving vulnerable adults residing in Medicaid-funded residential facilities.

State Medicaid authorities, including the Health Care Authority and Department of Social and Health Services, assisted significantly in the fraud enforcement of these matters.

  • Report suspected Medicaid fraud: 360-586-8888 or MFCUreferrals@atg.wa.gov.
  • You can also report provider fraud via the Attorney General’s Office Web site.

The DSHS Office of Fraud & Accountability investigates client fraud.  You can report Medicaid Client Fraud via the Department’s Online Complaint Form, call the Welfare Fraud Hotline at 1-800-562-6906 or send the complaint to Welfare Fraud Hotline, P.O. Box 45817, Olympia, Washington 98504-5817.